BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) can lead to significant changes to the HIV reservoir and HIV immune responses, indicating that further characterization of HIV-infected patients undergoing HSCT is warranted. METHODS: We studied 3 patients who underwent HSCT after either reduced intensity conditioning or myeloablative conditioning regimen. We measured HIV antigens and antibodies (Ag/Ab), HIV-specific CD4 T-cell responses, HIV RNA, and DNA in plasma, peripheral blood mononuclear cells, isolated CD4 T cells from peripheral blood, and lymph node cells. The patients remained on antiretroviral therapy throughout the follow-up period. RESULTS: All patients have been in continued remission for 4-6 years post-HSCT. Analyses of HIV RNA and DNA levels showed substantial reductions in HIV reservoir-related measurements in all 3 patients, changes in immune response varied with pronounced reductions in 2 patients and a less dramatic reduction in 1 patient. One patient experienced unexpected viral rebound 4 years after HSCT. CONCLUSIONS: These 3 cases highlight the substantial changes to the HIV reservoir and the HIV immune response in patients undergoing allogeneic HSCT. The viral rebound observed in 1 patient indicates that replication competent HIV can re-emerge several years after HSCT despite these marked changes.
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) can lead to significant changes to the HIV reservoir and HIV immune responses, indicating that further characterization of HIV-infectedpatients undergoing HSCT is warranted. METHODS: We studied 3 patients who underwent HSCT after either reduced intensity conditioning or myeloablative conditioning regimen. We measured HIV antigens and antibodies (Ag/Ab), HIV-specific CD4 T-cell responses, HIV RNA, and DNA in plasma, peripheral blood mononuclear cells, isolated CD4 T cells from peripheral blood, and lymph node cells. The patients remained on antiretroviral therapy throughout the follow-up period. RESULTS: All patients have been in continued remission for 4-6 years post-HSCT. Analyses of HIV RNA and DNA levels showed substantial reductions in HIV reservoir-related measurements in all 3 patients, changes in immune response varied with pronounced reductions in 2 patients and a less dramatic reduction in 1 patient. One patient experienced unexpected viral rebound 4 years after HSCT. CONCLUSIONS: These 3 cases highlight the substantial changes to the HIV reservoir and the HIV immune response in patients undergoing allogeneic HSCT. The viral rebound observed in 1 patient indicates that replication competent HIV can re-emerge several years after HSCT despite these marked changes.
Authors: Claudia F Althaus; Sara Gianella; Philip Rieder; Viktor von Wyl; Roger D Kouyos; Barbara Niederöst; Adrian Schmid; Karin J Metzner; Beda Joos; Huldrych F Günthard; Marek Fischer Journal: J Virol Methods Date: 2010-01-29 Impact factor: 2.014
Authors: Sharon R Lewin; John M Murray; Ajantha Solomon; Fiona Wightman; Paul U Cameron; Damian J Purcell; John J Zaunders; Pat Grey; Mark Bloch; Don Smith; David A Cooper; Anthony D Kelleher Journal: J Acquir Immune Defic Syndr Date: 2008-02-01 Impact factor: 3.731
Authors: Douglas D Richman; David M Margolis; Martin Delaney; Warner C Greene; Daria Hazuda; Roger J Pomerantz Journal: Science Date: 2009-03-06 Impact factor: 47.728
Authors: John J Zaunders; Mee Ling Munier; Nabila Seddiki; Sarah Pett; Susanna Ip; Michelle Bailey; Yin Xu; Kai Brown; Wayne B Dyer; Min Kim; Robert de Rose; Stephen J Kent; Lele Jiang; Samuel N Breit; Sean Emery; Anthony L Cunningham; David A Cooper; Anthony D Kelleher Journal: J Immunol Date: 2009-07-27 Impact factor: 5.422
Authors: Nabila Seddiki; Laura Cook; Denise C Hsu; Chansavath Phetsouphanh; Kai Brown; Yin Xu; Stephen J Kerr; David A Cooper; C Mee Ling Munier; Sarah Pett; Jintanat Ananworanich; John Zaunders; Anthony D Kelleher Journal: Eur J Immunol Date: 2014-04-29 Impact factor: 5.532
Authors: Timothy J Henrich; Emily Hanhauser; Francisco M Marty; Michael N Sirignano; Sheila Keating; Tzong-Hae Lee; Yvonne P Robles; Benjamin T Davis; Jonathan Z Li; Andrea Heisey; Alison L Hill; Michael P Busch; Philippe Armand; Robert J Soiffer; Marcus Altfeld; Daniel R Kuritzkes Journal: Ann Intern Med Date: 2014-09-02 Impact factor: 25.391
Authors: Sheila M Keating; Debra Hanson; Mila Lebedeva; Oliver Laeyendecker; N'ko L Ali-Napo; S Michele Owen; Susan L Stramer; Richard D Moore; Philip J Norris; Michael P Busch Journal: J Clin Microbiol Date: 2012-10-03 Impact factor: 5.948
Authors: Gero Hütter; Daniel Nowak; Maximilian Mossner; Susanne Ganepola; Arne Müssig; Kristina Allers; Thomas Schneider; Jörg Hofmann; Claudia Kücherer; Olga Blau; Igor W Blau; Wolf K Hofmann; Eckhard Thiel Journal: N Engl J Med Date: 2009-02-12 Impact factor: 91.245
Authors: Julian H Elliott; Fiona Wightman; Ajantha Solomon; Khader Ghneim; Jeffrey Ahlers; Mark J Cameron; Miranda Z Smith; Tim Spelman; James McMahon; Pushparaj Velayudham; Gregor Brown; Janine Roney; Jo Watson; Miles H Prince; Jennifer F Hoy; Nicolas Chomont; Rémi Fromentin; Francesco A Procopio; Joumana Zeidan; Sarah Palmer; Lina Odevall; Ricky W Johnstone; Ben P Martin; Elizabeth Sinclair; Steven G Deeks; Daria J Hazuda; Paul U Cameron; Rafick-Pierre Sékaly; Sharon R Lewin Journal: PLoS Pathog Date: 2014-11-13 Impact factor: 6.823
Authors: Steven A Yukl; Eli Boritz; Michael Busch; Christopher Bentsen; Tae-Wook Chun; Daniel Douek; Evelyn Eisele; Ashley Haase; Ya-Chi Ho; Gero Hütter; J Shawn Justement; Sheila Keating; Tzong-Hae Lee; Peilin Li; Danielle Murray; Sarah Palmer; Christopher Pilcher; Satish Pillai; Richard W Price; Meghan Rothenberger; Timothy Schacker; Janet Siliciano; Robert Siliciano; Elizabeth Sinclair; Matt Strain; Joseph Wong; Douglas Richman; Steven G Deeks Journal: PLoS Pathog Date: 2013-05-09 Impact factor: 6.823
Authors: Daniel D Murray; John Zaunders; Samuel T Milliken; C Mee Ling Munier; Carole Ford; C Orla Morrissey; Malini Visweswaran; Sharon Avery; Joseph Sasadeusz; John Kwan; Shrinivas Desai; Matthew Law; Kersten K Koelsch; Sharon R Lewin; John Moore; Anthony D Kelleher; Mark N Polizzotto Journal: Clin Infect Dis Date: 2021-04-08 Impact factor: 9.079
Authors: Richard F Ambinder; Juan Wu; Brent Logan; Christine M Durand; Ryan Shields; Uday R Popat; Richard F Little; Deborah K McMahon; Joshua Cyktor; John W Mellors; Ernesto Ayala; Lawrence D Kaplan; Ariela Noy; Richard J Jones; Alan Howard; Stephen J Forman; David Porter; Carlos Arce-Lara; Paul Shaughnessy; Lisa Sproat; Shahrukh K Hashmi; Adam M Mendizabal; Mary M Horowitz; Willis H Navarro; Joseph C Alvarnas Journal: Biol Blood Marrow Transplant Date: 2019-07-04 Impact factor: 5.742
Authors: Jason T Weinfurter; Saritha S D'Souza; Lea M Matschke; Sarah Bennett; Laurel E Kelnhofer-Millevolte; Kran Suknuntha; Akhilesh Kumar; Jennifer Coonen; Christian M Capitini; Peiman Hematti; Thaddeus G Golos; Igor I Slukvin; Matthew R Reynolds Journal: Sci Rep Date: 2022-07-19 Impact factor: 4.996
Authors: Analia Uruena; Isabel Cassetti; Neena Kashyap; Claire Deleage; Jacob D Estes; Christopher Trindade; Dima A Hammoud; Peter D Burbelo; Ven Natarajan; Robin Dewar; Hiromi Imamichi; Addison J Ward; April Poole; Alexander Ober; Catherine Rehm; Sara Jones; C Jason Liang; Tae-Wook Chun; Avindra Nath; H Clifford Lane; Bryan R Smith; Mark Connors; Stephen A Migueles Journal: Open Forum Infect Dis Date: 2020-12-15 Impact factor: 3.835
Authors: John Zaunders; Wayne B Dyer; Melissa Churchill; C Mee Ling Munier; Philip H Cunningham; Kazuo Suzuki; Kristin McBride; Will Hey-Nguyen; Kersten Koelsch; Bin Wang; Bonnie Hiener; Sarah Palmer; Paul R Gorry; Michelle Bailey; Yin Xu; Mark Danta; Nabila Seddiki; David A Cooper; Nitin K Saksena; John S Sullivan; Sean Riminton; Jenny Learmont; Anthony D Kelleher Journal: J Virus Erad Date: 2019-04-01
Authors: Ping-Hsien Lee; Michael D Keller; Patrick J Hanley; Catherine M Bollard Journal: Front Cell Infect Microbiol Date: 2020-07-07 Impact factor: 5.293